LOUIS CRENSHAW: Open Payments
NPI 1114994746 · PINEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,775 in 112 payments from 14 companies in 2025. Trend: 2023 $1,654 · 2024 $1,659 · 2025 $1,775
Food & beverage: $1,775
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 55 | $880 |
| Axsome Therapeutics, Inc. | 19 | $316 |
| Otsuka America Pharmaceutical, Inc. | 13 | $177 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $146 |
| Ardelyx, Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| PFIZER INC. | 2 | $31 |
| Novo Nordisk Inc | 1 | $26 |
| Abbott Laboratories | 1 | $22 |
Products named: QULIPTA, Auvelity, VRAYLAR, REXULTI, UBRELVY, CAPLYTA, IBSRELA, JARDIANCE.
Industry payments across LA — which companies pay providers there.
